시장보고서
상품코드
2023539

방사선의학용 AI 시장 분석 및 예측(-2035년) : 유형, 서비스, 기술, 용도, 도입 상황, 최종사용자, 솔루션

AI In Radiology Market Analysis and Forecast to 2035: Type, Services, Technology, Application, Deployment, End User, Solution

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 7,145,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 8,650,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 10,154,000
카드담기
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 방사선의학용 AI 시장은 2025년 320억 달러에서 2035년까지 2,491억 달러로 성장하며, CAGR은 18.6%에 달할 것으로 예측됩니다. GE헬스케어, 지멘스 헬스인어스 등의 기업이 병원과 영상 진단 센터에 AI 솔루션을 도입하고 있으며, 그 보급이 빠르게 확대되고 있습니다. 이용 현황은 분석된 영상 검사 건수로 측정됩니다. 가격은 일반적으로 기능 및 규모에 따라 솔루션 당 연간 1만 달러에서 10만 달러 이상까지 다양합니다. 구독형 또는 스캔당 과금 모델이 일반적입니다. 영상 검사 건수의 증가와 보다 신속하고 정확한 진단에 대한 니즈 증가가 도입 확대와 지출 증가의 원동력이 되고 있습니다.

AI 기반 알고리즘과 플랫폼이 영상의학 솔루션의 핵심을 이루고 있으므로 영상의학 AI 시장의 '유형' 부문은 소프트웨어가 주류를 이루고 있습니다. 이러한 소프트웨어 툴은 이미지 자동 분석, 이상 감지, 임상 의사결정 지원을 가능하게 하여 진단 정확도와 워크플로우의 효율성을 크게 향상시킵니다. 영상 데이터의 증가와 숙련된 영상의학과 전문의의 부족이 도입을 촉진하는 주요 요인으로 작용하고 있습니다. 하드웨어는 영상 진단 인프라를 지원하고 서비스는 도입과 유지보수를 보장하지만, AI 모델과 통합 기능의 지속적인 발전으로 소프트웨어가 여전히 주요 촉진요인으로 작용하고 있습니다.

응용 분야에서는 암의 조기 및 정확한 검출에 대한 높은 수요를 배경으로 종양학이 주도적인 역할을 하고 있습니다. AI를 활용한 방사선 의학 솔루션은 종양 식별, 질병 진행 상황 모니터링, 치료 계획 수립 지원에 폭넓게 활용되고 있습니다. 신경학 및 심장학도 중요한 분야로, AI는 고급 이미지 분석을 통해 뇌졸중, 심장병 등의 질병을 감지할 수 있도록 돕고 있습니다. 만성질환의 유병률 증가와 보다 신속하고 정확한 진단에 대한 요구가 증가함에 따라 이러한 응용 분야에서 방사선 의학에 AI를 도입하는 것이 가속화되고 있습니다.

지역별 개요

북미는 첨단 의료 인프라, 높은 의료 영상 기술 보급률, 임상 워크플로우에 대한 인공지능의 강력한 통합으로 인해 영상의학 분야 AI 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 미국은 이 분야를 선도하고 있으며, 병원과 진단센터에서 CT, MRI, 엑스레이 영상 판독에 AI를 활용한 툴이 널리 사용되고 있습니다. 주요 AI 의료 기업의 강력한 존재감과 디지털 헬스 혁신에 대한 막대한 투자가 결합되어 도입이 가속화되고 있습니다. 북미는 유리한 상환 제도, 높은 의료비 지출, AI 기반 진단 툴에 대한 지원적인 규제 승인으로 인해 글로벌 방사선 의학 AI 시장에서 북미의 우위를 더욱 강화하고 있습니다.

아시아태평양은 의료 시스템의 급속한 디지털화와 효율적인 진단 솔루션에 대한 수요 증가로 인해 방사선 의학 분야의 AI 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 중국, 인도, 일본, 한국 등의 국가들은 AI를 활용한 의료 인프라와 의료 영상 기술에 많은 투자를 하고 있습니다. 환자 수 증가, 방사선과 의사 부족, 만성질환 유병률 증가 등이 AI 기반 방사선 의학 툴의 도입을 촉진하고 있습니다. 스마트 병원과 원격 방사선 진단의 확대를 지원하는 정부의 노력이 성장을 더욱 가속화하고 있습니다. 또한 글로벌 AI 기업 및 현지 스타트업의 투자 확대로 아시아태평양은 가장 빠르게 성장하는 지역 시장으로 자리매김하고 있습니다.

주요 동향 및 촉진요인

더 빠르고 정확한 진단 영상에 대한 수요 증가

영상의학 분야 AI 시장의 주요 시장 촉진요인은 보다 신속하고 정확하며 효율적인 진단 영상 솔루션에 대한 요구가 증가하고 있다는 점입니다. CT, MRI, 엑스레이 스캔에서 얻을 수 있는 의료 영상 데이터의 양이 증가함에 따라 방사선과 의사의 업무가 과중해져 진단이 지연되거나 오진되는 경우가 발생하고 있습니다. AI를 활용한 영상의학 툴은 영상 분석의 자동화, 보다 정확한 이상 징후 감지 및 워크플로우의 효율화를 돕습니다. 이러한 기술은 특히 종양학, 신경학, 심혈관계 질환의 조기 발견을 돕습니다. 만성질환의 유병률 증가와 예방 의료에 대한 수요 증가로 인해 전 세계 의료 시스템에서 AI 기반 방사선 의학 솔루션의 도입이 더욱 가속화되고 있습니다.

AI 지원 진단 플랫폼 및 원격 진단 서비스 확대

영상의학에서 AI 시장의 큰 기회는 AI 지원 진단 플랫폼과 원격 방사선 진단 서비스의 확대에 있습니다. 인공지능과 클라우드 기반 영상 진단 시스템의 통합으로 실시간 분석 및 원격 진단이 가능해져 의료 서비스가 부족한 지역의 의료 접근성을 향상시킬 수 있습니다. 원격의료와 디지털 병원의 도입이 진행되고 있는 것도 AI를 활용한 영상의학 툴에 대한 수요를 더욱 촉진하고 있습니다. 또한 딥러닝 알고리즘과 이미지 인식 기술의 발전으로 진단의 정확성과 효율성이 향상되고 있습니다. 의료 제공자, AI 기업, 영상 진단 기기 제조업체 간의 협력이 확대되면서 전 세계에서 시장 기회가 크게 확대될 것으로 예상됩니다.

목차

제1장 개요

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 Global Insight Services 소개

KSA

The global AI in Radiology market is projected to grow from $32.0 billion in 2025 to $249.1 billion by 2035, at a compound annual growth rate (CAGR) of 18.6%. Adoption is growing rapidly, with increasing deployment of AI solutions across hospitals and imaging centers by companies like GE HealthCare and Siemens Healthineers. Usage is measured by the number of imaging studies analyzed. Pricing typically ranges from USD 10,000 to over USD 100,000 annually per solution, depending on features and scale. Subscription and per-scan pricing models are common. Rising imaging volumes and the need for faster, more accurate diagnostics are driving higher adoption and spending.

The Type segment in the AI in Radiology Market is dominated by software, as AI-driven algorithms and platforms form the core of radiology solutions. These software tools enable automated image analysis, anomaly detection, and clinical decision support, significantly improving diagnostic accuracy and workflow efficiency. The increasing volume of imaging data and the shortage of skilled radiologists are key factors driving adoption. While hardware supports imaging infrastructure, and services ensure implementation and maintenance, software remains the primary growth driver due to continuous advancements in AI models and integration capabilities.

Market Segmentation
TypeSoftware, Hardware, Services
ServicesIntegration Services, Maintenance Services, Consulting Services, Training Services
TechnologyMachine Learning, Deep Learning, Natural Language Processing, Computer Vision
ApplicationOncology, Cardiology, Neurology, Musculoskeletal, Respiratory
DeploymentCloud-Based, On-Premise, Hybrid
End UserHospitals, Diagnostic Centers, Research Institutes
SolutionDiagnostic Solutions, Imaging Solutions, Workflow Solutions

The Application segment is led by oncology, driven by the high demand for early and accurate cancer detection. AI-powered radiology solutions are widely used to identify tumors, monitor disease progression, and support treatment planning. Neurology and cardiology are also significant segments, where AI aids in detecting conditions such as stroke and heart disease through advanced imaging analysis. The growing prevalence of chronic diseases and the need for faster, more precise diagnostics are accelerating the adoption of AI in radiology across these application areas.

Geographical Overview

North America holds the largest market share in the AI in Radiology Market due to its advanced healthcare infrastructure, high adoption of medical imaging technologies, and strong integration of artificial intelligence in clinical workflows. The United States leads the region with widespread use of AI-powered tools in CT, MRI, and X-ray interpretation across hospitals and diagnostic centers. Strong presence of leading AI healthcare companies, combined with significant investments in digital health transformation, accelerates adoption. Favorable reimbursement structures, high healthcare expenditure, and supportive regulatory approvals for AI-based diagnostic tools further strengthen North America's dominant position in the global AI in radiology market.

Asia Pacific is expected to register the highest CAGR in the AI in Radiology Market due to rapid digitalization of healthcare systems and increasing demand for efficient diagnostic solutions. Countries such as China, India, Japan, and South Korea are investing heavily in AI-enabled healthcare infrastructure and medical imaging technologies. Rising patient populations, shortage of radiologists, and increasing prevalence of chronic diseases are driving adoption of AI-based radiology tools. Government initiatives supporting smart hospitals and tele-radiology expansion further accelerate growth. Additionally, growing investments from global AI companies and local startups are positioning Asia Pacific as the fastest-growing regional market.

Key Trends and Drivers

Rising demand for faster and more accurate diagnostic imaging

A key driver of the AI in Radiology Market is the increasing need for faster, more accurate, and efficient diagnostic imaging solutions. The growing volume of medical imaging data from CT, MRI, and X-ray scans is overwhelming radiologists, leading to delays and diagnostic errors. AI-powered radiology tools help automate image analysis, detect abnormalities with higher precision, and improve workflow efficiency. These technologies support early disease detection, particularly in oncology, neurology, and cardiovascular conditions. Rising prevalence of chronic diseases and increasing demand for preventive healthcare are further accelerating the adoption of AI-based radiology solutions across global healthcare systems.

Expansion of AI-enabled diagnostic platforms and teleradiology services

A major opportunity in the AI in Radiology Market lies in the expansion of AI-enabled diagnostic platforms and teleradiology services. The integration of artificial intelligence with cloud-based imaging systems allows real-time analysis and remote diagnosis, improving access to healthcare in underserved regions. Increasing adoption of telemedicine and digital hospitals is further driving demand for AI-powered radiology tools. Additionally, advancements in deep learning algorithms and image recognition technologies are enhancing diagnostic accuracy and efficiency. Growing collaborations between healthcare providers, AI companies, and imaging equipment manufacturers are expected to significantly expand market opportunities globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type (Software, Hardware, Services)
  • 2.2 Key Market Highlights by Solution (Diagnostic Solutions, Imaging Solutions, Workflow Solutions)
  • 2.3 Key Market Highlights by Services (Integration Services, Maintenance Services, Consulting Services, Training Services)
  • 2.4 Key Market Highlights by Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision)
  • 2.5 Key Market Highlights by Application (Oncology, Cardiology, Neurology, Musculoskeletal, Respiratory)
  • 2.6 Key Market Highlights by Deployment (Cloud-Based, On-Premise, Hybrid)
  • 2.7 Key Market Highlights by End User (Hospitals, Diagnostic Centers, Research Institutes)

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Software
    • 4.1.2 Hardware
    • 4.1.3 Services
  • 4.2 Market Size & Forecast by Solution (2020-2035)
    • 4.2.1 Diagnostic Solutions
    • 4.2.2 Imaging Solutions
    • 4.2.3 Workflow Solutions
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Integration Services
    • 4.3.2 Maintenance Services
    • 4.3.3 Consulting Services
    • 4.3.4 Training Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Machine Learning
    • 4.4.2 Deep Learning
    • 4.4.3 Natural Language Processing
    • 4.4.4 Computer Vision
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Oncology
    • 4.5.2 Cardiology
    • 4.5.3 Neurology
    • 4.5.4 Musculoskeletal
    • 4.5.5 Respiratory
  • 4.6 Market Size & Forecast by Deployment (2020-2035)
    • 4.6.1 Cloud-Based
    • 4.6.2 On-Premise
    • 4.6.3 Hybrid
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Centers
    • 4.7.3 Research Institutes

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Solution
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Deployment
      • 5.2.1.7 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Solution
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Deployment
      • 5.2.2.7 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Solution
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Deployment
      • 5.2.3.7 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Solution
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Deployment
      • 5.3.1.7 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Solution
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Deployment
      • 5.3.2.7 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Solution
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Deployment
      • 5.3.3.7 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Solution
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Deployment
      • 5.4.1.7 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Solution
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Deployment
      • 5.4.2.7 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Solution
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Deployment
      • 5.4.3.7 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Solution
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Deployment
      • 5.4.4.7 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Solution
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Deployment
      • 5.4.5.7 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Solution
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Deployment
      • 5.4.6.7 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Solution
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Deployment
      • 5.4.7.7 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Solution
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Deployment
      • 5.5.1.7 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Solution
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Deployment
      • 5.5.2.7 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Solution
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Deployment
      • 5.5.3.7 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Solution
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Deployment
      • 5.5.4.7 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Solution
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Deployment
      • 5.5.5.7 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Solution
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Deployment
      • 5.5.6.7 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Solution
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Deployment
      • 5.6.1.7 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Solution
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Deployment
      • 5.6.2.7 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Solution
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Deployment
      • 5.6.3.7 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Solution
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Deployment
      • 5.6.4.7 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Solution
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Deployment
      • 5.6.5.7 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Siemens Healthineers
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 GE Healthcare
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Philips Healthcare
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 IBM Watson Health
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Zebra Medical Vision
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aidoc
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Arterys
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 EnvoyAI
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Fujifilm Holdings
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Canon Medical Systems
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Nuance Communications
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 iCAD
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Riverain Technologies
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lunit
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Qure.ai
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Vuno
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 DeepMind
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 RadNet
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hologic
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Butterfly Network
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기